CTEV vs EXLS vs JPM vs BAC vs EPAM

For growth investors, EPAM Systems, Inc.

(EPAM) is the stronger pick with 15. 4% revenue growth year-over-year, versus -0. 5% for Bank of America Corporation (BAC). EPAM Systems, Inc. (EPAM) offers the better valuation at 11. 4x trailing P/E (5. 9x forward), making it the more compelling value choice. Analysts rate Claritev Corporation (CTEV) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, EPAM Systems, Inc.

(EPAM) is the cheapest at 11. 4x versus ExlService Holdings, Inc. at 16. 8x. On forward P/E, EPAM Systems, Inc. is actually cheaper at 5. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ExlService Holdings, Inc. wins at 0. 48x versus EPAM Systems, Inc. 's 1. 58x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, JPMorgan Chase & Co.

(JPM) delivered a total return of +135. 5%, compared to -85. 0% for EPAM Systems, Inc. (EPAM). Over 10 years, the gap is even starker: JPM returned +481. 2% versus CTEV's +0. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), ExlService Holdings, Inc.

(EXLS) is the lower-risk stock at 0. 42β versus Claritev Corporation's 2. 26β — meaning CTEV is approximately 432% more volatile than EXLS relative to the S&P 500. On balance sheet safety, EPAM Systems, Inc. (EPAM) carries a lower debt/equity ratio of 4% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), EPAM Systems, Inc.

(EPAM) is pulling ahead at 15. 4% versus -0. 5% for Bank of America Corporation (BAC). On earnings-per-share growth, the picture is similar: Claritev Corporation grew EPS 83. 0% year-over-year, compared to -14. 3% for EPAM Systems, Inc.. Over a 3-year CAGR, EXLS leads at 13. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

JPMorgan Chase & Co.

(JPM) is the more profitable company, earning 20. 4% net margin versus -29. 4% for Claritev Corporation — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus 4. 7% for CTEV. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, ExlService Holdings, Inc. (EXLS) is the more undervalued stock at a PEG of 0. 48x versus EPAM Systems, Inc. 's 1. 58x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, EPAM Systems, Inc. (EPAM) trades at 5. 9x forward P/E versus 14. 6x for JPMorgan Chase & Co. — 8. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EPAM: 88. 7% to $144. 63.

In this comparison, BAC (2.

3% yield), JPM (1. 8% yield) pay a dividend. CTEV, EXLS, EPAM do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, JPMorgan Chase & Co.

(JPM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 87), 1. 8% yield, +481. 2% 10Y return). Claritev Corporation (CTEV) carries a higher beta of 2. 26 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (JPM: +481. 2%, CTEV: +0. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (CTEV (Healthcare) and EXLS (Technology) and JPM (Financial Services) and BAC (Financial Services) and EPAM (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: CTEV is a small-cap quality compounder stock; EXLS is a small-cap deep-value stock; JPM is a large-cap deep-value stock; BAC is a large-cap deep-value stock; EPAM is a small-cap high-growth stock. JPM, BAC pay a dividend while CTEV, EXLS, EPAM do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.